
An Update on the Global Intellectual Property Landscape (with Michael Rosen)
One year ago, the Biden administration announced its support for a proposal at the World Trade Organization (WTO) that would waive Trade-Related Aspects of Intellectual Property (TRIPS) protections for COVID-19 vaccines and treatments. Last week, WTO member states agreed to a limited waiver that only covers vaccines and patents—not therapeutics or trade secrets. Both sides of the debate are relatively unhappy with this outcome. Does this mean it was a good compromise, or did the WTO somehow fall short in its duties? How is the Biden administration doing on other intellectual property (IP)…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.